Navigation Links
Breast cancer cells growing in 3D-matrix revert to normal
Date:12/17/2012

Human breast cancer cells growing in the lab on a three-dimensional (3-D) extracellular matrix reverted to a normal phenotype when subjected to compression force applied by an elastic chamber, researchers reported on Dec. 17 at the American Society for Cell Biology Annual Meeting in San Francisco.

Gautham Venugopalan, PhD, of the University of California, Berkeley, bioengineering lab of Daniel Fletcher, PhD, described how applying compressive force to malignant breast epithelial cells growing within a laminin-rich 3-D extracellular matrix caused them to turn into highly organized, growth-arrested acini, the milk-secreting spherical structures that are central to breast tissue.

This "phenotypic reversion" was accomplished without pharmacological agents, noted Dr. Venugopalan. Research collaborators included Kandice Tanner, PhD, and Mina Bissell, PhD, of the Lawrence Berkeley National Laboratory in Berkeley.

During a woman's reproductive life, breast tissue continuously grows, shrinks, and remodels in a highly regulated fashion. When this process breaks down, growth becomes abnormal.

Although genetic mutations are the classic explanation for differences between healthy and malignant cells but they don't tell the whole story because malignant cells treated with certain drugs will grow into organized acini that appear very similar to the healthy acini, even though they remain genetically malignant. This indicates that malignant cells have not completely "forgotten" how to be healthy, since they can be guided back into their "normal" growth program by giving them the right cues, according to Dr. Venugopalan.

Could mechanical force also reprogram malignant cells? The researchers seeded malignant breast epithelial cells into a 3-D laminin-rich extracellular matrix and used an elastic chamber to apply a compressive force. Over time, the compressed malignant cells grew into more organized, healthy-looking acini that resembled normal structures, even without the addition of exogenous drugs.

However, when the researchers added a drug that blocked E-cadherin, a transmembrane protein that helps cells adhere to their neighbors, the compression lost all effect, and the cells returned to their disorganized malignant appearance.

Previous studies have shown that healthy breast cells rotate as they form acini to help them organize into spherical structures, according to Dr. Venugopalan. This coherence is lost in malignant cells, so the researchers investigated whether rotation was affected by compression. By performing time-lapse microscopy over several days, they found that compression was inducing rotation in the malignant cells, further suggesting the importance of cell-cell communication during growth.

"Our findings suggest that external forces can encourage malignant cells to re-enter the correct morphogenetic program," said Dr. Venugopalan.
'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814

John Fleischman
jfleischman@ascb.org
513-706-0212

American Society for Cell Biology
Source:Eurekalert


Related biology technology :

1. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
2. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
3. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
4. Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
5. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
6. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
7. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
8. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
9. Silicone Scandal: Stem Cell Breast Augmentation a Safe Alternative
10. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
11. Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... Colo. (PRWEB) , ... January 11, 2017 , ... ... the journal Clinical Cancer Research show early promise of the investigational anti-cancer agent ... despite a median 5 previous treatment regimens. Twenty-seven percent of these heavily pretreated ...
(Date:1/11/2017)... 2017  Brian Mehling, M.D., world-renowned stem cell researcher, ... International (BHI), will be attending the 47th Annual World ... from January 17-20, 2017. This will be Dr. Mehling,s ... theme of this year,s forum is Responsive and Responsible ... address strategies for fostering greater social inclusion and human ...
(Date:1/11/2017)... ... 2017 , ... IsoPlexis Corporation (IsoPlexis), a venture-capital ... the proteomic function of individual cells in patients, today announced it was recently ... National Institute on Aging of the National Institutes of Health to develop a ...
(Date:1/11/2017)... ... January 11, 2017 , ... Advanced Polymer ... its team. Bernhard Bartylla will lead European initiatives for APMT’s product lines serving ... ACOMP and ARGEN to European manufacturers and researchers. Bernhard brings significant experience in ...
Breaking Biology Technology:
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/15/2016)... 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... announced today that on December 13, 2016, it received ... Nasdaq Stock Market LLC which acknowledged that, as of ... common stock had been at $1.00 or greater for ... with Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
Breaking Biology News(10 mins):